☆ 4.7 Letter

Independent assessment of lenvatinib plus everolimus in patients with metastatic renal cell carcinoma

LANCET ONCOLOGY (2016)

Journal

LANCET ONCOLOGY

Volume 17, Issue 1, Pages E4-E5

Publisher

ELSEVIER SCIENCE INC

DOI: 10.1016/S1470-2045(15)00543-4

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.